Viral evasion and challenges of hepatitis C virus vaccine development.

Viral evasion and challenges of hepatitis C virus vaccine development.

Item
http://www.wikidata.org/entity/Q38961608
Accelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers.Direct-acting antiviral agents for HCV infection affecting people who inject drugs.Immune Evasion Strategies during Chronic Hepatitis B and C Virus InfectionStructure-Based Design of Hepatitis C Virus Vaccines that Elicit Neutralizing Antibody Responses to a Conserved Epitope.Designing a B Cell-Based Vaccine against a Highly Variable Hepatitis C Virus.Mapping Determinants of Virus Neutralization and Viral Escape for Rational Design of a Hepatitis C Virus Vaccine.Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design.Predicting the Effectiveness of Hepatitis C Virus Neutralizing Antibodies by Bioinformatic Analysis of Conserved Epitope Residues Using Public Sequence Data.Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression
P2860

Viral evasion and challenges of hepatitis C virus vaccine development.

Item
http://www.wikidata.org/entity/Q38961608
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Viral evasion and challenges of hepatitis C virus vaccine development.
@en
type
label
Viral evasion and challenges of hepatitis C virus vaccine development.
@en
prefLabel
Viral evasion and challenges of hepatitis C virus vaccine development.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P50
P577
P698
P932
P356
P1433
P1476
Viral evasion and challenges of hepatitis C virus vaccine development.
@en
P2093
P2860
P304
P31
P356
10.1016/J.COVIRO.2016.09.004
P478
P50
P577
P698
P932